Trials / Conditions / Castration Resistant Prostatic Neoplasms
Castration Resistant Prostatic Neoplasms
5 registered clinical trials studyying Castration Resistant Prostatic Neoplasms.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC NCT05191017 | Nuvation Bio Inc. | Phase 1 / Phase 2 |
| Terminated | NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid NCT05252390 | Nuvation Bio Inc. | Phase 1 |
| Terminated | Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors NCT04541225 | Nuvation Bio Inc. | Phase 1 |
| Completed | Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer NCT04381832 | Arcus Biosciences, Inc. | Phase 1 / Phase 2 |
| Completed | A Study of Cetrelimab (JNJ-63723283), a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Com NCT03551782 | Janssen Research & Development, LLC | Phase 1 |